Product containing precisely naloxone hydrochloride 2.5 milligram and oxycodone hydrochloride 5 milligram/1 each modified-release oral tablet 1 tablet tablet (clinical drug)
| Code | 15852911000001109 |
|---|---|
| Semantic tag | clinical drug |
| Module | uk-clinical |
| Definition | defined |
| Effective time | 20250924 |
776864003Oxycodone + Naloxone
product
10363801000001108Virtual medicinal product
product
38420111000001105Myloxifin 5mg/2.5mg modified-release tablets (Ridge Pharma Ltd)
real clinical drug
38803111000001103Oxyargin 5mg/2.5mg modified-release tablets (Viatris UK Healthcare Ltd)
real clinical drug
42757411000001104Sofonac 5mg/2.5mg modified-release tablets (G.L. Pharma UK Ltd)
real clinical drug
37389611000001101Targinact 5mg/2.5mg modified-release tablets (CST Pharma Ltd)
real clinical drug
38168311000001100Targinact 5mg/2.5mg modified-release tablets (DE Pharmaceuticals)
real clinical drug
15850911000001105Targinact 5mg/2.5mg modified-release tablets (Napp Pharmaceuticals Ltd)
real clinical drug
42883911000001108Targinact 5mg/2.5mg modified-release tablets (Necessity Supplies Ltd)
real clinical drug
37704911000001106Targinact 5mg/2.5mg modified-release tablets (Pilsco Ltd)
real clinical drug
21503311000001105Targinact 5mg/2.5mg modified-release tablets (Waymade Healthcare Plc)
real clinical drug